|
|
|
Different regions of the brain and spinal cord house different, specialized cells. Neuralstem’s technology enables the isolation and expansion of human neural stem cells from each of these regions of the developing central nervous system (CNS) in virtually unlimited numbers from a single donated tissue. More |
Neuralstem’s technology uniquely enables the creation of stable neural stem cell lines from the human hippocampus, a part of the brain involved in memory and the generation of new neurons. From these cell lines, the company can create practically unlimited amounts of hippocampal neural stem cells. More |
Three lumbar patients approved to return as final cohort in Phase I trial, would be the first to receive stem cell transplantation along the length of the spinal cord. More
Safe, reproducible and robust route of administration of neural stem cells into the human spine is reinforced by report on trial interim data of first 12 patients. More
View poster presentation here
Four additional patients will complete this industry-leading trial whose final phase represents first transplantation directly into the gray matter of the spinal cord's cervical region. More
FDA greenlights 28-day dosing, in depressed patients, of NSI-189 which stimulates new neuron growth in the hippocampus, in ongoing clinical trial designed in collaboration with Harvard's Dr. Fava. More
Newsweek's Science Columnist and Science Editor Sharon Begley reports on Neuralstem's ongoing ALS trial at Emory. More
U.S. Department of Defense awards Neuralstem a contract to develop its human neural stem cell technology for the treatment of cancerous brain tumors. The company is engineering its cells to attack brain cancer in three ways. More
